IGXT =MC $34 M--FDA DECISION for Migraine Drug & Launch of Cannabis Products both expected during this Quarter !!!! Intelgenx (IGXT) Market Cap $34 M Cannabis-Infused VersaFilmĀ® Remains on Track for Commercial Launch in Q1-2020 IntelGenx Continues to Make Preparations Ahead of RIZAPORTĀ® PDUFA Goal Date of March 26, 2020 s2.q4cdn.com/790425727/files/images/pipline/2019/Picture1.jpg